Shayan Monabbati , Germán Corredor , Tilak Pathak , Craig Peacock , Kailin Yang , Shlomo Koyfman , Peter Scacheri , James Lewis Jr , Anant Madabhushi , Satish E. Viswanath , Berkley Gryder
{"title":"病理指纹鉴定肿瘤形态和表观遗传状态之间的关系","authors":"Shayan Monabbati , Germán Corredor , Tilak Pathak , Craig Peacock , Kailin Yang , Shlomo Koyfman , Peter Scacheri , James Lewis Jr , Anant Madabhushi , Satish E. Viswanath , Berkley Gryder","doi":"10.1016/j.ejca.2025.115429","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Measuring the chromatin state of a tumor provides a powerful map of its epigenetic commitments; however, as these are generally bulk measurements, it has not yet been possible to connect changes in chromatin accessibility to the pathological signatures of complex tumors. In parallel, recent advances in computational pathology have enabled the identification of spatial features and immune cells within oral cavity tumors and their microenvironment.</div></div><div><h3>Methods</h3><div>Here, we present pathogenomic fingerprinting (PaGeFin), a novel method that integrates morphological tumor features with chromatin states using ATAC-seq. This framework links spatial morphologic and epigenetic features, offering insights into tumor progression and immune evasion within and across tumors. Morphologic features describing spatial relationships between tumor and lymphocyte cells that are prognostic of oral cavity squamous cell carcinoma (OSCC) were identified through AI-driven pathology analysis. These pathomic features were spatially colocalized within the epigenome of 4 distinct sections of 4 OSCC tumors.</div></div><div><h3>Results</h3><div>These key features pinpointed chromatin regions responsible for critical immune cell function through peak locations and enrichment analysis, highlighting loci of CD27+ memory B cells, helper CD4+ T cells, and cytotoxic CD8 naïve T cells that likely drive morphologic changes in the distribution of lymphocytes in the tumor microenvironment and promote aggressive tumor behavior. Gene Ontology analysis revealed that the <em>CTLA4, CD79A, CD3D,</em> and <em>CCR7</em> genes were embedded in these regions.</div></div><div><h3>Conclusion</h3><div>This computational approach is the first to assess the correlation between pathomic and epigenetic features in the context of cancer.</div></div>","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"221 ","pages":"Article 115429"},"PeriodicalIF":7.6000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pathogenomic fingerprinting to identify associations between tumor morphology and epigenetic states\",\"authors\":\"Shayan Monabbati , Germán Corredor , Tilak Pathak , Craig Peacock , Kailin Yang , Shlomo Koyfman , Peter Scacheri , James Lewis Jr , Anant Madabhushi , Satish E. Viswanath , Berkley Gryder\",\"doi\":\"10.1016/j.ejca.2025.115429\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Measuring the chromatin state of a tumor provides a powerful map of its epigenetic commitments; however, as these are generally bulk measurements, it has not yet been possible to connect changes in chromatin accessibility to the pathological signatures of complex tumors. In parallel, recent advances in computational pathology have enabled the identification of spatial features and immune cells within oral cavity tumors and their microenvironment.</div></div><div><h3>Methods</h3><div>Here, we present pathogenomic fingerprinting (PaGeFin), a novel method that integrates morphological tumor features with chromatin states using ATAC-seq. This framework links spatial morphologic and epigenetic features, offering insights into tumor progression and immune evasion within and across tumors. Morphologic features describing spatial relationships between tumor and lymphocyte cells that are prognostic of oral cavity squamous cell carcinoma (OSCC) were identified through AI-driven pathology analysis. These pathomic features were spatially colocalized within the epigenome of 4 distinct sections of 4 OSCC tumors.</div></div><div><h3>Results</h3><div>These key features pinpointed chromatin regions responsible for critical immune cell function through peak locations and enrichment analysis, highlighting loci of CD27+ memory B cells, helper CD4+ T cells, and cytotoxic CD8 naïve T cells that likely drive morphologic changes in the distribution of lymphocytes in the tumor microenvironment and promote aggressive tumor behavior. Gene Ontology analysis revealed that the <em>CTLA4, CD79A, CD3D,</em> and <em>CCR7</em> genes were embedded in these regions.</div></div><div><h3>Conclusion</h3><div>This computational approach is the first to assess the correlation between pathomic and epigenetic features in the context of cancer.</div></div>\",\"PeriodicalId\":11980,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"221 \",\"pages\":\"Article 115429\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2025-04-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0959804925002102\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804925002102","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Pathogenomic fingerprinting to identify associations between tumor morphology and epigenetic states
Introduction
Measuring the chromatin state of a tumor provides a powerful map of its epigenetic commitments; however, as these are generally bulk measurements, it has not yet been possible to connect changes in chromatin accessibility to the pathological signatures of complex tumors. In parallel, recent advances in computational pathology have enabled the identification of spatial features and immune cells within oral cavity tumors and their microenvironment.
Methods
Here, we present pathogenomic fingerprinting (PaGeFin), a novel method that integrates morphological tumor features with chromatin states using ATAC-seq. This framework links spatial morphologic and epigenetic features, offering insights into tumor progression and immune evasion within and across tumors. Morphologic features describing spatial relationships between tumor and lymphocyte cells that are prognostic of oral cavity squamous cell carcinoma (OSCC) were identified through AI-driven pathology analysis. These pathomic features were spatially colocalized within the epigenome of 4 distinct sections of 4 OSCC tumors.
Results
These key features pinpointed chromatin regions responsible for critical immune cell function through peak locations and enrichment analysis, highlighting loci of CD27+ memory B cells, helper CD4+ T cells, and cytotoxic CD8 naïve T cells that likely drive morphologic changes in the distribution of lymphocytes in the tumor microenvironment and promote aggressive tumor behavior. Gene Ontology analysis revealed that the CTLA4, CD79A, CD3D, and CCR7 genes were embedded in these regions.
Conclusion
This computational approach is the first to assess the correlation between pathomic and epigenetic features in the context of cancer.
期刊介绍:
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.